Identification of recurrent and novel mutations in TULP1 in Pakistani families with early-onset retinitis pigmentosa by Ajmal, M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/108208
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
Identification of recurrent and novel mutations in TULP1 in
Pakistani families with early-onset retinitis pigmentosa
Muhammad Ajmal,1,2,3 Muhammad Imran Khan,1,2 Shazia Micheal,1,2 Waqas Ahmed,1 Ashfa Shah,3
Hanka Venselaar,4,5 Habib Bokhari,1 Aisha Azam,6 Nadia Khalida Waheed,3,7 Rob W.J. Collin,2,5,8
Anneke I. den Hollander,2,5,8 Raheel Qamar,1,3 Frans P. M. Cremers1,2,5
(The first two authors contributed equally to this work)
1Department of Biosciences, Faculty of Science, COMSATS Institute of Information Technology, Islamabad, Pakistan; 2Department
of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; 3Shifa College of Medicine,
Islamabad, Pakistan; 4Centre for Molecular and Biomolecular Informatics, Radboud University Nijmegen Medical Centre,
Nijmegen, The Netherlands; 5Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre,
Nijmegen, The Netherlands; 6Institute of Ophthalmology, Mayo Hospital, Lahore, Pakistan; 7Shifa International Hospital,
Islamabad, Pakistan; 8Department of Ophthalmology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Purpose: To identify the genetic defects underlying retinitis pigmentosa (RP) in Pakistani families.
Methods: Genome-wide high-density single-nucleotide-polymorphism microarray analysis was performed using the
DNA of nine affected individuals from two large families with multiple consanguineous marriages. Data were analyzed
to identify homozygous regions that are shared by affected sibs in each family. Sanger sequencing was performed for
genes previously implicated in autosomal recessive RP and allied retinal dystrophies that resided in the identified
homozygous regions. Probands from both families underwent fundus examination and electroretinogram measurements.
Results: The tubby-like protein 1 gene (TULP1) was present in the largest homozygous region in both families. Sequence
analysis identified a previously reported mutation (c.1138A>G; p.Thr380Ala) in one family and a novel pathogenic variant
(c.1445G>A; p.Arg482Gln) in the other family. Both variants were found to be present in a homozygous state in all
affected individuals, were heterozygous present in the unaffected parents, and heterozygous present or absent in normal
individuals. Affected individuals of both families showed an early-onset form of RP.
Conclusions: Homozygosity mapping, combined with candidate-gene analysis, successfully identified genetic defects in
TULP1 in two large Pakistani families with early-onset retinitis pigmentosa.
The major cause of inherited blindness in humans is
retinitis pigmentosa (RP; OMIM 268000). The clinical
symptoms of RP are the loss of night vision in the early phase
of disease, later followed by peripheral vision loss, tunnel
vision, and sometimes complete blindness [1]. Progression of
the disease is mainly caused by the gradual loss of rod
photoreceptor cells, which are mostly responsible for vision
under low light conditions, and the subsequent loss of cone
photoreceptor cells, which are involved in color vision under
bright light conditions. The clinical diagnosis is based on
fundus examination and electrophysiological analysis of rod
and cone photoreceptor-cell function by measuring the
scotopic and photopic responses, respectively, using
electroretinography (ERG). The disease’s characteristics are
the presence of pigmentary deposits (bone spicules) in the
peripheral fundus, diminished or no ERG responses from rod
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and cone photoreceptor cells, and attenuation of the retinal
blood vessels [1].
The disease is highly genetically heterogeneous, since 55
different genes and three loci have been identified as being
associated with nonsyndromic RP (RetNet, Nov. 8, 2011). All
Mendelian forms of inheritance have been observed for RP.
Digenic forms and rare mitochondrial inheritance have also
been reported [1-4].
Tubby-like protein 1 (TULP1; OMIM 602280) belongs
to the tubby-like protein family. The TULP1 gene is located
on the short arm of chromosome 6 [5]. TULP1 is expressed
specifically in the retina [5,6], and the encoded protein is
thought to be involved in protein trafficking, such as the
transport of rhodopsin from the inner segment to the outer
segment via the connecting cilium [7].
The aim of the current study was to identify the
underlying genetic causes of autosomal recessive RP (arRP)
in Pakistani families by using genome-wide homozygosity
mapping and Sanger sequencing of known retinal disease
genes in the homozygous regions. We identified disease-
causing mutations in TULP1 in two large families.
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METHODS
Ethics committee/institutional review board approval: Before
initiating this study, approval for this work was granted by the
Ethics Committee/Institutional Review Board of the Shifa
College of Medicine/Shifa International Hospital, Islamabad,
Pakistan, and signed informed consent was obtained from all
participating individuals in both families.
Ascertainment of families and clinical analysis: Two families
from the Punjab province with individuals having night vision
and daytime vision loss were included in the study. Their
pedigrees were drawn (Figure 1A,B) using Haplopainter [8],
and venous blood samples were collected in acid citrate
dextrose-containing vacutainers (Becton Dickinson, Franklin
Lakes, NJ). Fundus examinations were done, and ERG [9]
measurements were made for probands in both families.
Figure 1. Pedigrees and TULP1 genotyping results for families A and B. A: This is the pedigree of family A in which the presence of the c.
1138A>G variant (M) was found in a homozygous state in all affected individuals. As expected for causal autosomal recessive variants,
unaffected parents are heterozygous, and normal individuals carry one or no mutant allele. B: This is the pedigree of family B in which the
presence of the c.1445G>A variant (M) was shown in a homozygous state in the 6 affected individuals, and heterozygously in an unaffected
sibling, parents and grandparents of affected persons. C: This is the sequence electropherogram showing the nucleotide change from adenine
to guanine in the proband of family A (upper panel), and sequence electropherogram of a control individual showing the wild-type adenine
(lower panel). D: This is the sequence electropherogram of the proband carrying the mutant adenine in family B (upper panel); and the sequence
electropherogram of a control individual with the normal guanine (lower panel). Probands are indicated with arrows; asterisks indicate the
individuals that were tested using HumanOmniExpress (>700K) SNP microarrays. M/M, homozygous c.1138A>G (in family A) or
homozygous c.1445G>A (in family B); +/M, heterozygous mutations present; +/+, two wild-type alleles present.
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Genotype analysis and homozygosity mapping: DNA was
extracted by using a standard phenol chloroform extraction
protocol [10] and stored at 4 °C. HumanOmniExpress (>700
K) single nucleotide polymorphism (SNP) microarrays from
Illumina Inc. (San Diego, CA) were employed to search for
homozygous regions in six affected individuals (Figure 1A)
in family A and three affected individuals (Figure 1B) in
family B. Genotype data were analyzed with Homozygosity
Mapper [11], an online tool for homozygosity mapping using
SNP genotyping data. Haplotype comparisons were also done
for affected and normal individuals to identify the
homozygous regions that were identical in all the affected
individuals in each family.
Sequence analysis and mutation detection: Prior to Sanger
sequencing, the 15 protein-coding exons of TULP1 and their
flanking intronic sequences were amplified by PCR using
standard conditions and reagents. PCR primers were designed
with the online primer-designing tool Primer3 [12] (available
on request). Amplified PCR products were electrophoresed in
2% agarose gels containing ethidium bromide, and DNA
bands were visualized on an ultraviolet transilluminator. PCR
products were purified on PCR clean-up purification plates
(NucleoFast™ 96 PCR, Cat. No. 743100.10; MACHEREY-
NAGEL, Düren, Germany), according to the manufacturer’s
protocol. Purified PCR products were subsequently used for
Sanger sequencing in an automated DNA sequencer (Big Dye
Terminator, version 3, on a 3730 DNA analyzer; Applied
Biosystems, Foster City, CA).
Sequencing results were analyzed by using Vector NTI
Advance™ 2011 software from Life Technologies/Invitrogen
(Bleiswijk, Netherlands), by assembling the sequenced
contigs and then visualizing the aligned sequences of the
exons.
Pathogenicity assessment of identified variants: Identified
missense variants were assessed for possible causality by
using sorting intolerant from tolerant (SIFT) analysis and
polymorphism phenotyping (Polyphen).
Restriction fragment length polymorphism analysis:
Restriction fragment length polymorphism analysis was
performed to detect the presence or absence, of the identified
mutations, in 100 ethnically matched control individuals. For
the mutation identified in family A, restriction enzyme
HpyCH4III was used, whereas in family B, restriction enzyme
MspI was used. In both families, restriction enzyme
recognition sites were abolished in the mutant sequences.
Purified PCR products were used for restriction enzyme
digestion, according to the manufacturer’s protocol (New
England BioLabs, Ipswich, MA).
Evolutionary conservation of amino acids: To check the
evolutionary conservation of the mutated amino acids, the
TULP1 orthologous protein sequences of the following
species were aligned with the Vector NTI Advance™ 2011
software: humans (H. sapiens, ENSP00000229771);
chimpanzees (P. troglodytes, ENSPTRP00000007764); mice
(M. musculus, ENSMUSP00000049070); dogs (C.
familiaris, ENSCAFP00000001922); chickens (G. gallus,
ENSGALP00000009613); frogs (X. tropicalis,
ENSXETP00000000899); tetraodons (T. nigroviridis,
ENSTNIP00000004001); fruitflies (D. melanogaster,
FBpp0088961); honeybees (A. mellifera, GB19892-PA);
roundworms (C. elegans, F10B5.4), blood flukes (S.
mansoni, Smp_058730__mRNA); and Arabidopsis (A.
thaliana, AT1G76900.1).
Three-dimensional structure prediction: Project HOPE [13]
was used to predict the possible structural changes in the
mutant TULP1 proteins identified in our study using a normal
TULP1 structure (PDB-file 3C5N).
RESULTS
In both families, the average age of disease onset was in the
first decade of life. Ophthalmic examination of affected
individuals from both families revealed the presence of
attenuated retinal vessels and the optic disc to have a waxy,
pale appearance (Figure 2). A yellow perifoveal annular ring,
a characteristic feature of individuals carrying TULP1
mutations, was also clearly visible in family A (Figure 2A,B).
In family B, the perifoveal ring was in the process of
development (Figure 2C,D). Upon ERG, scotopic and
photopic electrophysiological responses of rod and cone
photoreceptors, respectively, were diminished in affected
members of both families (Table 1). Neither nystagmus nor
eye poking were present in either family.
Genome-wide SNP microarray data of six affected
individuals of family A were analyzed with the help of
homozygosity mapper, which revealed a single homozygous
region (Figure 3A) of 3.9 Mb (from 32.9 Mb to 36.8 Mb; hg19)
on chromosome 6, flanked by SNPs rs3132131 and
rs236411. This homozygous region harbored TULP1, a gene
known to be mutated in patients with Leber congenital
amaurosis (LCA) and arRP. The sequence analysis identified
a previously reported mutation, c.1138A>G (p.Thr380Ala)
[14,15] in this family (Figure 1C).
Similarly, genome-wide SNP microarray data analysis of
three affected individuals of family B, resulted in the
identification of six homozygous regions (Figure 3B). After
haplotype comparison, two regions, a 4.8 Mb region on
chromosome 6 (from 33.8 Mb to 38.6 Mb, flanked by SNPs
rs9296102 and rs7761629) and a 1.4 Mb region on
chromosome 7 (from 132.3 Mb to 133.7 Mb, flanked by SNPs
rs924368 and rs10249912), were found to be identical in all
the affected individuals. TULP1 resides in the homozygous
region on chromosome 6, and the sequence analysis revealed
a novel mutation, c.1445G>A (p.Arg482Gln; Figure 1C). The
homozygous chromosomal region on chromosome 7 did not
contain a gene previously implicated in an inherited retinal
disease such as arRP or LCA.
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Figure 2. Fundus photographs of affected individuals from both families and of a normal individual. A, B: Right and left fundus, respectively,
of the proband of family A (see arrow, Figure 1A), representative of the fundus appearance of all affected members of this family. Arrows
indicate yellow perifoveal annular rings. C, D: Right and left fundus, respectively, of the proband of family B (see arrow, Figure 1B).
Arrowheads point to the developing perifoveal annular rings. E, F: Right and left fundus, respectively, of a normal individual.
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In families A and B, the variants c.1138A>G and c.
1445G>A, respectively, were found to be present in a
homozygous state in all affected individual, were
heterozygous present in the unaffected parents, and absent or
heterozygous present in normal individuals (Figure 1A,B).
Both wild-type nucleotides were shown to be highly
conserved, as evidenced by their phylogenetic p value [16]
scores of 2.87 (c.1138A) and 6.10 (c.1445G) for family A and
B, respectively. In addition, the encoded amino acids,
p.Thr380 and p.Arg482, located in the C-terminal tubby
domain, are highly conserved among different vertebrate and
invertebrate species, while in a plant (Arabidopsis), isoleucine
is present instead of threonine (Figure 4). These amino acids
are completely conserved among the tubby, TULP1, TULP2,
and TULP3 proteins [17]. SIFT predicts that both TULP1
variants are “not tolerated” whereas Polyphen predicts that
both are “probably damaging” with prediction scores of 0.827
and 1.000 for p.Thr380Ala and p.Arg482Gln, respectively.
A three-dimensional-structure prediction analysis by
project HOPE predicts that the p.Thr380Ala mutation, due to
the smaller size of the alanine residue, causes an empty space
in the protein and possible rearrangements of surrounding
residues (Figure 5A,B). Any hydrogen bonds made by
threonine will also be lost, because alanine is a hydrophobic
residue. Very close to Thr380 is a predicted inositol
triphosphate binding site that might also be influenced by local
conformational changes. The p.Arg482Gln variant changes a
positively charged amino acid (arginine) to a neutral residue
(glutamine), which results in the loss of interactions with
negatively charged residues in its vicinity (Figure 5C). In view
of its location in the three-dimensional structure, these
changes may result in a loss of external interactions.
The p.Thr380Ala and p.Arg482Gln variants were not
detected in 100 healthy ethnically matched control
individuals.
Figure 3. Homozygosity mapping results for families A and B. Homozygosity-mapper plots show the homozygous regions in the affected
individuals in both families (red lines). Homozygous regions that show identical haplotypes for all affected individuals within a family are
indicated by arrows. Panel A represents family A and panel B represents family B.
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DISCUSSION
In the current study, we report on two large families with
several consanguineous marriages and multiple individuals
with early-onset RP that were found to carry TULP1
mutations. Family A had 27 affected individuals who resided
in the northern part of the Punjab province. This family had a
strong custom of marrying inside the family. TULP1
mutations were previously reported to cause LCA, a
congenital form of severe vision impairment or blindness and
early-onset RP [14,15,18-31]. There is clinical and genetic
overlap between (early-onset) arRP and LCA [32,33], and
often it is very difficult to differentiate between these two
conditions. Mutations in Crumbs homolog 1 (CRB1), Lecithin
retinol acyltransferase (LRAT), Mer tyrosine kinase
protooncogene (MERTK), Retinal pigment epithelium-
specific protein, 65-KD (RPE65), Spermatogenesis-
associated protein 7 (SPATA7), and TULP1 have been
identified in individuals with LCA and arRP [18-21,34-47].
If a severe form of rod–cone dystrophy is observed beyond
early childhood, and when there are no features reminiscent
of LCA, such as nystagmus, or eye poking, the phenotype is
classified as early-onset RP.
Figure 4. Conservation of mutated
amino acids among different species.
Amino acids identical to human tubby-
like protein 1 (TULP1) amino acids are
shaded in gray. The positions of the
amino acids in the respective
polypeptides are indicated.
Figure 5. Three-dimensional domain
architecture of the tubby domain of
TULP1 wild-type and mutant proteins.
A: Preferred predicted secondary
structure of normal tubby-like protein 1
(TULP1) with Thr380 and Arg482
indicated in green. In yellow, the
inositol triphosphate molecules that are
predicted to bind the tubby domain of
TULP1. B: Predicted structure of part of
the p.Thr380Ala mutant protein in
affected individuals of family A. The
smaller size of the alanine residue may
lead to rearrangements of surrounding
residues and thereby affect putative
inositol triphosphate binding. C: Part of
the predicted structure of the
p.Arg482Gln mutant protein found in
affected individuals of family B. The
p.Arg482Gln variant changes a
positively charged amino acid
(arginine) to a neutral residue
(glutamine), which leads to loss of
interactions with two negatively
charged residues in its vicinity. Wild-
type interactions are indicated with
yellow blocks.
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TULP family proteins (TUB, TULP1, TULP2, and
TULP3) have crucial roles in embryonic development in
vertebrates and take part in the proper functioning of the
central nervous system [6,48]. TULP1 is expressed
specifically in the rod and cone photoreceptor cells [5,6], and
is involved in the transport of rhodopsin [7]. In Tulp1−/− mice,
photoreceptor degeneration precedes synaptic malfunction,
and thus TULP1 may have a function in photoreceptor
synapse development [49]. A mutation of the same residue
(p.Arg482Trp) was earlier found in combination with
p.Leu504fsX140 in five affected individuals with severe
early-onset RP [50].
The structural analyses of the TULP1 C-terminal
domains of the mutant proteins suggest that the missense
mutations identified in our study might have resulted in the
destabilization of the mutant proteins, or might have
influenced the putative interactions of the tubby domain.
Among different species of animals and plants, p.Arg482 is
located in the signature sequence (F-[KRHQ]-G-R-V-[ST]-x-
A-S-V-K-N-F-Q) of the Tubby family of proteins, and this
signature sequence contains 11 invariant amino acids that are
highly conserved (Prosite) [5]. Replacement of the wild-type
residue with the mutant glutamine might affect the signature
sequence; this might ultimately prevent the mutant TULP1
protein from functioning normally.
In family A, the presence of a typical yellow-colored
perifoveal annular ring was also indicative of TULP1
involvement [24]; whereas in family B, the ring formation was
incomplete (Figure 2C,D). The bone spicules absent from
both families might still develop later in life. The age of both
individuals who were clinically evaluated was 20 years.
The previously identified mutation p.Thr380Ala has only
been reported in two unrelated Pakistani families [14,15]. Our
findings concerning this mutation in yet another Pakistani
family suggested that c.1138A>G might be a Pakistani
founder mutation, although no link was established between
any of these families. One family belonged to a northern area
of Pakistan [14] while the other belonged to the southern part
of Punjab [15]. Our family belonged to the northern part of
Punjab, which, however, does not exclude the possibility that
this mutation represents a founder mutation in Pakistan.
Including our findings, 26 different TULP1 mutations
have been identified in 33 families (Table 2). TULP1
mutations were found in 4.3% (10/231) of LCA families
[14,18,24,25,27,29,30] and 2.4% (23/948) of arRP families
[15,19-24,26,28,30,31,50]. TULP1 mutations causing arRP or
LCA include two nonsense, two frame-shift, and seven splice-
site mutations; a six-base-pair duplication; and 14 missense
mutations (Table 2). Splice-site and protein-truncating
mutations are distributed throughout the gene (Figure 6A),
whereas the missense mutations are only present in the C-
terminal tubby domain of TULP1 (Figure 6B).
TULP1 mutations are a frequent cause of LCA and arRP,
and therefore represent an attractive therapeutic target. Thus
far, TULP1 mutations have been found in a total of 136
individuals with LCA or arRP (Table 2). Through our studies,
33 additional patients with TULP1 mutations might benefit
from genetic counseling and future gene-augmentation
therapy.
In conclusion, we were able to identify one novel (c.
1445G>A; p.Arg482Gln) and one previously identified (c.
1138A>G; p.Thr380Ala) disease-causing mutation in
TULP1 in Pakistani families with early-onset RP.
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